Zobrazeno 1 - 10
of 2 190
pro vyhledávání: '"Loo YM"'
Autor:
Cai Y; Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD 20878, USA., Diallo S; Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD 20878, USA., Rosenthal K; Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD 20878, USA., Ren K; Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD 20878, USA., Flores DJ; Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD 20878, USA., Dippel A; Biologics Engineering, Oncology R&D, AstraZeneca, Gaithersburg, MD 20878, USA., Oganesyan V; Biologics Engineering, Oncology R&D, AstraZeneca, Gaithersburg, MD 20878, USA., van Dyk N; Biologics Engineering, Oncology R&D, AstraZeneca, Gaithersburg, MD 20878, USA., Chen X; Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD 20878, USA., Cantu E; Imaging and Data Analytics, AstraZeneca, Gaithersburg, MD 20878, USA., Choudhary R; Imaging and Data Analytics, AstraZeneca, Gaithersburg, MD 20878, USA., Sulikowski M; Imaging and Data Analytics, AstraZeneca, Cambridge CB2 0AA, UK., Adissu H; Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD 20878, USA., Chawla B; BIOQUAL Inc., Rockville, MD 20850, USA., Kar S; BIOQUAL Inc., Rockville, MD 20850, USA., Liu C; Chinese Academy of Medical Science (CAMS) Oxford Institute, University of Oxford, Oxford OX3 7BN, UK.; Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, UK., Dijokaite-Guraliuc A; Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, UK., Mongkolsapaya J; Chinese Academy of Medical Science (CAMS) Oxford Institute, University of Oxford, Oxford OX3 7BN, UK.; Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, UK.; Mahidol-Oxford Tropical Medicine Research Unit, Bangkok, Thailand, Department of Medicine, University of Oxford, Oxford OX3 7BN, UK., Rajan S; Biologics Engineering, Oncology R&D, AstraZeneca, Gaithersburg, MD 20878, USA., Loo YM; Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD 20878, USA., Beavon R; Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Cambridge CB2 8PA, UK., Webber C; Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Cambridge CB2 8PA, UK., Chang LJ; Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD 20878, USA., Thomas S; Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD 20878, USA., Clegg L; Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD 20878, USA., Zhang H; Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD 20878, USA., Screaton GR; Chinese Academy of Medical Science (CAMS) Oxford Institute, University of Oxford, Oxford OX3 7BN, UK.; Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, UK., Philbin N; Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Cambridge CB2 8PA, UK., Harre M; Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Cambridge CB2 8PA, UK., Selim A; Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Cambridge CB2 8PA, UK., Martinez-Alier N; Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Cambridge CB2 8PA, UK., Uriel A; Department of Infectious Diseases and Tropical Medicine, North Manchester General Hospital (Manchester University NHS Foundation Trust), Manchester M8 5RB, UK., Cohen TS; Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD 20878, USA., Perez JL; Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD 20878, USA., Esser MT; Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD 20878, USA., Blair W; Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD 20878, USA., Francica JR; Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD 20878, USA.
Publikováno v:
Science translational medicine [Sci Transl Med] 2024 Jun 26; Vol. 16 (753), pp. eado2817. Date of Electronic Publication: 2024 Jun 26.
Autor:
Sankhala RS; Emerging Infectious Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, MD, USA; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, USA., Dussupt V; Emerging Infectious Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, MD, USA; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, USA; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, USA., Chen WH; Emerging Infectious Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, MD, USA; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, USA., Bai H; Emerging Infectious Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, MD, USA; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, USA; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, USA., Martinez EJ; Emerging Infectious Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, MD, USA; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, USA., Jensen JL; Emerging Infectious Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, MD, USA; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, USA., Rees PA; Emerging Infectious Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, MD, USA; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, USA., Hajduczki A; Emerging Infectious Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, MD, USA; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, USA., Chang WC; Emerging Infectious Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, MD, USA; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, USA., Choe M; Emerging Infectious Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, MD, USA; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, USA., Yan L; Department of Microbiology and Immunology, Uniformed Services University, Bethesda, MD, USA., Sterling SL; Department of Microbiology and Immunology, Uniformed Services University, Bethesda, MD, USA., Swafford I; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, USA; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, USA., Kuklis C; Viral Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, MD, USA., Soman S; Viral Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, MD, USA., King J; Viral Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, MD, USA., Corbitt C; Viral Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, MD, USA., Zemil M; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, USA; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, USA., Peterson CE; Emerging Infectious Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, MD, USA; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, USA., Mendez-Rivera L; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, USA; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, USA., Townsley SM; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, USA; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, USA., Donofrio GC; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, USA; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, USA., Lal KG; Emerging Infectious Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, MD, USA; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, USA; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, USA., Tran U; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, USA; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, USA., Green EC; Department of Microbiology and Immunology, Uniformed Services University, Bethesda, MD, USA., Smith C; Center for Molecular Microscopy, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, USA; Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc., Frederick, MD, USA., de Val N; Center for Molecular Microscopy, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, USA; Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc., Frederick, MD, USA., Laing ED; Department of Microbiology and Immunology, Uniformed Services University, Bethesda, MD, USA., Broder CC; Department of Microbiology and Immunology, Uniformed Services University, Bethesda, MD, USA., Currier JR; Viral Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, MD, USA., Gromowski GD; Viral Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, MD, USA., Wieczorek L; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, USA; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, USA., Rolland M; Emerging Infectious Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, MD, USA; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, USA; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, USA., Paquin-Proulx D; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, USA; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, USA., van Dyk D; Antibody Discovery and Protein Engineering (ADPE), BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA., Britton Z; Antibody Discovery and Protein Engineering (ADPE), BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA., Rajan S; Antibody Discovery and Protein Engineering (ADPE), BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA., Loo YM; Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA., McTamney PM; Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA., Esser MT; Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA., Polonis VR; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, USA., Michael NL; Center for Infectious Diseases Research, Walter Reed Army Institute of Research, Silver Spring, MD, USA., Krebs SJ; Emerging Infectious Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, MD, USA; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, USA; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, USA. Electronic address: skrebs@hivresearch.org., Modjarrad K; Emerging Infectious Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, MD, USA., Joyce MG; Emerging Infectious Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, MD, USA; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, USA. Electronic address: gjoyce@eidresearch.org.
Publikováno v:
Structure (London, England : 1993) [Structure] 2024 Feb 01; Vol. 32 (2), pp. 131-147.e7. Date of Electronic Publication: 2023 Dec 28.
Autor:
Hemann EA; Department of Immunology, Center for Innate Immunity and Immune Disease, University of Washington, Seattle, WA.; Department of Microbial Infection and Immunity, The Ohio State University, Columbus, OH., Knoll ML; Department of Immunology, Center for Innate Immunity and Immune Disease, University of Washington, Seattle, WA., Wilkins CR; Department of Immunology, Center for Innate Immunity and Immune Disease, University of Washington, Seattle, WA., Subra C; The Henry M. Jackson Foundation for the Advancement of Military Medicine and the U.S. Military HIV Research Program, Bethesda, MD., Green R; Department of Immunology, Center for Innate Immunity and Immune Disease, University of Washington, Seattle, WA., García-Sastre A; The Henry M. Jackson Foundation for the Advancement of Military Medicine and the U.S. Military HIV Research Program, Bethesda, MD.; Department of Microbiology, The Tisch Cancer Institute, Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY.; Department of Pathology, Molecular and Cell-Based Medicine, The Tisch Cancer Institute, Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY., Thomas PG; Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN., Trautmann L; The Henry M. Jackson Foundation for the Advancement of Military Medicine and the U.S. Military HIV Research Program, Bethesda, MD.; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR., Ireton RC; Department of Immunology, Center for Innate Immunity and Immune Disease, University of Washington, Seattle, WA., Loo YM; Department of Immunology, Center for Innate Immunity and Immune Disease, University of Washington, Seattle, WA., Gale M Jr.; Department of Immunology, Center for Innate Immunity and Immune Disease, University of Washington, Seattle, WA.
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2023 May 01; Vol. 210 (9), pp. 1247-1256.
Autor:
Dippel A; Biologics Engineering, R&D, AstraZeneca, Gaithersburg, MD, USA., Gallegos A; Biopharmaceuticals Development, R&D, AstraZeneca, Gaithersburg, MD, USA., Aleti V; Biologics Engineering, R&D, AstraZeneca, Gaithersburg, MD, USA., Barnes A; Biologics Engineering, R&D, AstraZeneca, Gaithersburg, MD, USA., Chen X; Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Gaithersburg, MD, USA., Christian E; Biopharmaceuticals Development, R&D, AstraZeneca, Gaithersburg, MD, USA., Delmar J; Biopharmaceuticals Development, R&D, AstraZeneca, Gaithersburg, MD, USA., Du Q; Biologics Engineering, R&D, AstraZeneca, Gaithersburg, MD, USA., Esfandiary R; Biopharmaceuticals Development, R&D, AstraZeneca, Gaithersburg, MD, USA., Farmer E; Biopharmaceuticals Development, R&D, AstraZeneca, Gaithersburg, MD, USA., Garcia A; Biologics Engineering, R&D, AstraZeneca, Gaithersburg, MD, USA., Li Q; Hansoh Bio, Rockville, MD, USA.; Biologics Engineering, R&D, AstraZeneca, Gaithersburg, MD, USA., Lin J; Biologics Engineering, R&D, AstraZeneca, Gaithersburg, MD, USA., Liu W; Pfizer, La Jolla, CA, USA.; Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Gaithersburg, MD, USA., Machiesky L; Biopharmaceuticals Development, R&D, AstraZeneca, Gaithersburg, MD, USA., Mody N; Biopharmaceuticals Development, R&D, AstraZeneca, Gaithersburg, MD, USA., Parupudi A; Biopharmaceuticals Development, R&D, AstraZeneca, Gaithersburg, MD, USA., Prophet M; Biopharmaceuticals Development, R&D, AstraZeneca, Gaithersburg, MD, USA., Rickert K; Biologics Engineering, R&D, AstraZeneca, Gaithersburg, MD, USA., Rosenthal K; Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA., Ren S; Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Gaithersburg, MD, USA., Shandilya H; Biologics Engineering, R&D, AstraZeneca, Gaithersburg, MD, USA., Varkey R; Biologics Engineering, R&D, AstraZeneca, Gaithersburg, MD, USA., Wons K; Biopharmaceuticals Development, R&D, AstraZeneca, Gaithersburg, MD, USA., Wu Y; Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Gaithersburg, MD, USA., Loo YM; Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA., Esser MT; Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA., Kallewaard NL; Eli Lilly, Indianapolis, IN, USA.; Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA., Rajan S; Biologics Engineering, R&D, AstraZeneca, Gaithersburg, MD, USA., Damschroder M; Biologics Engineering, R&D, AstraZeneca, Gaithersburg, MD, USA., Xu W; Biopharmaceutical Development, MacroGenics, Rockville, MD, USA.; Biopharmaceuticals Development, R&D, AstraZeneca, Gaithersburg, MD, USA., Kaplan G; Biologics Engineering, R&D, AstraZeneca, Gaithersburg, MD, USA.
Publikováno v:
MAbs [MAbs] 2023 Jan-Dec; Vol. 15 (1), pp. 2152526.
Autor:
Nkolola JP; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA 02115, USA., Yu J; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA 02115, USA., Wan H; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA 02115, USA., Chang A; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA 02115, USA., McMahan K; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA 02115, USA., Anioke T; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA 02115, USA., Jacob-Dolan C; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA 02115, USA., Powers O; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA 02115, USA., Ye T; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA 02115, USA., Chandrashekar A; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA 02115, USA., Sellers D; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA 02115, USA., Barrett J; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA 02115, USA., Loo YM; Microbial Sciences, AstraZeneca, Gaithersburg, MD 20878, USA., Esser MT; Microbial Sciences, AstraZeneca, Gaithersburg, MD 20878, USA., Carnahan RH; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA.; Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN 37232, USA., Crowe JE Jr; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA.; Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN 37232, USA.; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN 37232, USA., Barouch DH; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA 02115, USA.; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA.
Publikováno v:
Science translational medicine [Sci Transl Med] 2022 Oct 05; Vol. 14 (665), pp. eabo6160. Date of Electronic Publication: 2022 Oct 05.
Autor:
Case JB; Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA., Mackin S; Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.; Department of Pathology & Immunology, Washington University School of Medicine, St. Louis, MO, USA., Errico JM; Department of Pathology & Immunology, Washington University School of Medicine, St. Louis, MO, USA., Chong Z; Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA., Madden EA; Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA., Whitener B; Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA., Guarino B; Humabs BioMed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland., Schmid MA; Humabs BioMed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland., Rosenthal K; Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA., Ren K; Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA., Dang HV; Vir Biotechnology, San Francisco, CA, USA., Snell G; Vir Biotechnology, San Francisco, CA, USA., Jung A; Department of Pathology & Immunology, Washington University School of Medicine, St. Louis, MO, USA., Droit L; Department of Pathology & Immunology, Washington University School of Medicine, St. Louis, MO, USA., Handley SA; Department of Pathology & Immunology, Washington University School of Medicine, St. Louis, MO, USA., Halfmann PJ; Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI, USA., Kawaoka Y; Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI, USA.; Division of Virology, Institute of Medical Science, University of Tokyo, Tokyo, Japan.; The Research Center for Global Viral Diseases, National Center for Global Health and Medicine Research Institute, Tokyo, Japan., Crowe JE Jr; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN, USA.; Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA.; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA., Fremont DH; Department of Pathology & Immunology, Washington University School of Medicine, St. Louis, MO, USA.; Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO, USA.; Department of Biochemistry & Molecular Biophysics, Washington University School of Medicine, St. Louis, MO, USA., Virgin HW; Department of Pathology & Immunology, Washington University School of Medicine, St. Louis, MO, USA.; Vir Biotechnology, San Francisco, CA, USA.; University of Texas Southwestern Medical Center, Dallas, TX, USA., Loo YM; Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA., Esser MT; Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA., Purcell LA; Vir Biotechnology, San Francisco, CA, USA., Corti D; Humabs BioMed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland., Diamond MS; Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA. mdiamond@wustl.edu.; Department of Pathology & Immunology, Washington University School of Medicine, St. Louis, MO, USA. mdiamond@wustl.edu.; Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO, USA. mdiamond@wustl.edu.; Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, Saint Louis, MO, USA. mdiamond@wustl.edu.; Center for Vaccines and Immunity to Microbial Pathogens, Washington University School of Medicine, Saint Louis, MO, USA. mdiamond@wustl.edu.
Publikováno v:
Nature communications [Nat Commun] 2022 Jul 02; Vol. 13 (1), pp. 3824. Date of Electronic Publication: 2022 Jul 02.
Autor:
Loo YM; Virology and Vaccine Discovery, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD 20878, USA., McTamney PM; Virology and Vaccine Discovery, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD 20878, USA., Arends RH; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD 20878, USA., Abram ME; Translational Medicine, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD 20878, USA., Aksyuk AA; Translational Medicine, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD 20878, USA., Diallo S; Virology and Vaccine Discovery, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD 20878, USA., Flores DJ; Virology and Vaccine Discovery, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD 20878, USA., Kelly EJ; Translational Medicine, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD 20878, USA., Ren K; Virology and Vaccine Discovery, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD 20878, USA., Roque R; Virology and Vaccine Discovery, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD 20878, USA., Rosenthal K; Virology and Vaccine Discovery, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD 20878, USA., Streicher K; Translational Medicine, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD 20878, USA., Tuffy KM; Translational Medicine, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD 20878, USA., Bond NJ; Analytical Sciences, BioPharmaceuticals R&D, AstraZeneca, Granta Park, Cambridge CB21 6GH, UK., Cornwell O; Analytical Sciences, BioPharmaceuticals R&D, AstraZeneca, Granta Park, Cambridge CB21 6GH, UK., Bouquet J; Integrated Bioanalysis, Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, San Francisco, CA 94080, USA., Cheng LI; Oncology Safety Pathology, Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD 20878, USA., Dunyak J; Clinical Pharmacology and Pharmacometrics, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD 20878, USA., Huang Y; Integrated Bioanalysis, Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, San Francisco, CA 94080, USA., Rosenbaum AI; Integrated Bioanalysis, Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, San Francisco, CA 94080, USA., Pilla Reddy V; Clinical Pharmacology and Pharmacometrics, BioPharmaceuticals R&D, AstraZeneca, Granta Park, Cambridge CB21 6GH, UK., Andersen H; BIOQUAL Inc., Rockville, MD 20850, USA., Carnahan RH; Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN 37232, USA.; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA., Crowe JE Jr; Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN 37232, USA.; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA.; Department of Pathology, Microbiology and Immunology, Vanderbilt University, Nashville, TN 37232, USA., Kuehne AI; USAMRIID, Fort Detrick, MD 21702-5011, USA., Herbert AS; USAMRIID, Fort Detrick, MD 21702-5011, USA., Dye JM; USAMRIID, Fort Detrick, MD 21702-5011, USA., Bright H; Virology and Vaccine Discovery, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD 20878, USA., Kallewaard NL; Virology and Vaccine Discovery, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD 20878, USA., Pangalos MN; BioPharmaceuticals R&D, AstraZeneca, Cambridge CB21 6GH, UK., Esser MT; Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD 20878, USA.
Publikováno v:
Science translational medicine [Sci Transl Med] 2022 Mar 09; Vol. 14 (635), pp. eabl8124. Date of Electronic Publication: 2022 Mar 09.
Autor:
Dong J; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN, USA., Zost SJ; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN, USA., Greaney AJ; Basic Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Department of Genome Sciences & Medical Scientist Training Program, University of Washington, Seattle, WA, USA., Starr TN; Basic Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Dingens AS; Basic Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Chen EC; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA., Chen RE; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA.; Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA., Case JB; Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA., Sutton RE; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN, USA., Gilchuk P; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN, USA., Rodriguez J; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN, USA., Armstrong E; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN, USA., Gainza C; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN, USA., Nargi RS; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN, USA., Binshtein E; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN, USA., Xie X; Department of Biochemistry & Molecular Biology, The University of Texas Medical Branch at Galveston, Galveston, TX, USA., Zhang X; Department of Biochemistry & Molecular Biology, The University of Texas Medical Branch at Galveston, Galveston, TX, USA., Shi PY; Department of Biochemistry & Molecular Biology, The University of Texas Medical Branch at Galveston, Galveston, TX, USA., Logue J; Department of Microbiology and Immunology, The University of Maryland, College Park, MD, USA., Weston S; Department of Microbiology and Immunology, The University of Maryland, College Park, MD, USA., McGrath ME; Department of Microbiology and Immunology, The University of Maryland, College Park, MD, USA., Frieman MB; Department of Microbiology and Immunology, The University of Maryland, College Park, MD, USA., Brady T; Microbial Sciences, AstraZeneca, Gaithersburg, MD, USA., Tuffy KM; Microbial Sciences, AstraZeneca, Gaithersburg, MD, USA., Bright H; Microbial Sciences, AstraZeneca, Gaithersburg, MD, USA., Loo YM; Microbial Sciences, AstraZeneca, Gaithersburg, MD, USA., McTamney PM; Microbial Sciences, AstraZeneca, Gaithersburg, MD, USA., Esser MT; Microbial Sciences, AstraZeneca, Gaithersburg, MD, USA., Carnahan RH; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN, USA.; Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA., Diamond MS; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA.; Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.; Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO, USA.; Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, St. Louis, MO, USA., Bloom JD; Basic Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Department of Genome Sciences & Medical Scientist Training Program, University of Washington, Seattle, WA, USA.; Howard Hughes Medical Institute, Seattle, WA, USA., Crowe JE Jr; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN, USA. james.crowe@vumc.org.; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA. james.crowe@vumc.org.; Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA. james.crowe@vumc.org.
Publikováno v:
Nature microbiology [Nat Microbiol] 2021 Oct; Vol. 6 (10), pp. 1233-1244. Date of Electronic Publication: 2021 Sep 21.
Genetic and structural basis for recognition of SARS-CoV-2 spike protein by a two-antibody cocktail.
Autor:
Dong J, Zost S, Greaney A, Starr TN, Dingens AS, Chen EC, Chen R, Case B, Sutton R, Gilchuk P, Rodriguez J, Armstrong E, Gainza C, Nargi R, Binshtein E, Xie X, Zhang X, Shi PY, Logue J, Weston S, McGrath M, Frieman M, Brady T, Tuffy K, Bright H, Loo YM, McvTamney P, Esser M, Carnahan R, Diamond M, Bloom J, Crowe JE
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2021 Mar 01. Date of Electronic Publication: 2021 Mar 01.
Autor:
Klimaj, Stefan D.1 (AUTHOR), LaPointe, Autumn1 (AUTHOR), Martinez, Kimberly1 (AUTHOR), Acosta, Eduardo Hernandez1 (AUTHOR), Kell, Alison M.1 (AUTHOR) amkell@salud.unm.edu
Publikováno v:
PLoS Pathogens. 11/25/2024, Vol. 20 Issue 11, p1-25. 25p.